Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: A case report and literature review

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 11, 2004, Pages 836-840

  Kanafani, Z A ^a   Comair, Y ^a   Kanj, S S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; CLOTRIMAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; TERBINAFINE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; AMPUTATION; ANAMNESIS; ARTHRODESIS; ARTHROTOMY; BACTERIUM CULTURE; BONE EXAMINATION; CASE REPORT; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DEBRIDEMENT; DECOMPRESSION SURGERY; DRUG TOLERABILITY; EXCISION; FEMALE; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; LAMINECTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PETRIELLIDIUM BOYDII; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKULL; SKULL RADIOGRAPHY; SUBDURAL EMPYEMA; SYNOVECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; EMPYEMA, SUBDURAL; FEMALE; HUMANS; MYCOSES; OSTEOMYELITIS; PSEUDALLESCHERIA; PYRIMIDINES; TRIAZOLES;

EID: 15044364598     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1233-2     Document Type: Review

References (44)

1. Warintarawej A, Winter WG Jr, Goodman NL (1975) Maduromycosis (Madura foot) in Kentucky. South Med J 68:1570-1575
2. Hospenthal DR, Bennett JB (2000) Miscellaneous fungi and prototheca. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2772-2773
3. Fernandez-Guerrero ML, Ruiz Barnes P, Ales JM (1987) Postcraniotomy mycetoma of the scalp and osteomyelitis due to Pseudallescheria boydii. J Infect Dis 156:855
4. Lang AG, Peterson HA (1976) Osteomyelitis following puncture wounds of the foot in children. J Trauma 16:993-999
5. Halpern AA, Nagel DA, Schurman DJ (1997) Allescheria bovdii osteomyelitis following multiple steroid injections and surgery. Clin Orthop 126:232-234
6. Lichtman DM, Johnson DC, Mack GR, Lack EE (1978) Maduromycosis (Allescheria boydii) infection of the hand. A case report. J Bone Joint Surg Am 60:546-548
7. Lutwick LI, Rytel MW, Yanez JP, Galgiani JN, Stevens DA (1979) Deep infections from Petriellidium boydii treated with miconazole. J Am Med Assoc 241:272-273
8. Kemp HB, Bedford AF, Fincham WJ (1982) Petriellidium boydii infection of the knee: a case report. Skeletal Radiol 9:114-117
9. Galgiani JN, Stevens DA, Graybill JR, Stevens DL, Tillinghast AJ, Levine HB (1984) Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven patients and in vitro susceptibility results. Chest 86:219-224
10. Travis LB, Roberts GD, Wilson WR (1985) Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin Proc 60:531-537
11. Ansari RA, Hindson DA, Stevens DL, Kloss JG (1987) Pseudallescheria boydii arthritis and osteomyelitis in a patient with Cushing's disease. South Med J 80:90-92
12. Piper JP, Golden J, Brown D, Broestler J (1990) Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 9:674-675
13. Hung LH, Norwood LA (1993) Osteomyelitis due to Pseudallescheria boydii. South Med J 86:231-234
14. Dellestable F, Kures L, Mainard D, Pere P, Gaucher A (1994) Fungal arthritis due to Pseudallescheria boydii (Scedosporium apiospermum). J Rheumatol 21:766-768
15. Foster MR, Friedenberg ZB, Passero F (1994) Lumbar Petriellidium boydii osteomyelitis with a systemic presentation. J Spinal Disord 7:356-360
16. Hung CC, Chang SC, Yang PC, Hsieh WC (1994) Invasive pulmonary pseudallescheriasis with direct invasion of the thoracic spine in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 13:749-751
17. Gatto J, Paterson D, Davis L, Lockwood L, Allworth A (1997) Vertebral osteomyelitis due to Pseudallescheria boydii. Pathology 29:238-240
18. Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA (1998) Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 29:1266-1272
19. Horre R, Feil E, Stangel AP (2000) Scedosporiosis of the brain with fatal outcome after traumatizatio of the foot. Case report. Mycoses 43(Suppl 2):33-36
20. Lonser RR, Brodke DS, Dailey AT (2001) Vertebral osteomyelitis secondary to Pseudallescheria boydii. J Spinal Disord 14:361-364
21. Levine NB, Kurokawa R, Fichtenbaum CJ, Howington JA, Kuntz C (2002) An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis. J Spinal Disord Tech 15:425-430
22. Talbot TR, Hatcher J, Davis SF, Pierson IIIrd RN, Barton R, Dummer S (2002) Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation 74:1645-1647
23. Fays S, Di Cesare MP, Antunes A, Truchetet F (2002) Cutaneous and osteoarticular Scedosporium apiospermum infection. Ann Med Interne (Paris) 153:537-539
24. Lazarus HS, Myers JP, Brocker PJ (1986) Post-craniotomy wound infection caused by Pseudallescheria boydii. Case report. J Neurosurg 64:153-154
25. Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL (1999) Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 43:149-151
26. Johnson EM, Szekely A, Warnock DW (1998) In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 42:741-745
27. Walsh TJ, Hiemenz JW, Seibel NL et al (1998) Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 26:1383-1396
28. Drouhet E, Dupont B (1987) Evolution of antifungal agents: past, present, and future. Rev Infect Dis 9(Suppl 1):4-14
29. Nesky MA, McDougal EC, Peacock JE Jr (2000) Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 31:673-677
30. Pfaller MA, Marco F, Messer SA, Jones RN (1998) In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 30:251-255
31. Safdar A, Papadopoulos EB, Young JW (2002) Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 4:212-217
32. Girmenia C, Luzi G, Monaco M, Martino P (1998) Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 36:1436-1438
33. Munoz P, Marin M, Tornero P, Martin Rabadan P, Rodriguez-Creixems M, Bouza E (2000) Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 31:1499-1501
34. Jabado N, Casanova JL, Haddad E et al (1998) Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 27:1437-1441
35. Poza G, Montoya J, Redondo C et al (2000) Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin Infect Dis 30:981-982
36. Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE (2002) In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 46:62-68
37. Espinel-Ingroff A (2001) In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 39:954-958
38. McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG (1997) In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother 41:1832-1834
39. Sheehan DJ, Hitchcock CA, Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12:40-79
40. Shouldice E, Fernandez C, McCully B, Schmidt M, Fraser R, Cook C (2003) Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia. J Pediatr Hematol Oncol 25:732-734
41. Steinbach WJ, Schell WA, Miller JL, Perfect JR (2003) Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol 41:3981-3985
42. Studahl M, Backteman T, Stalhammar F, Chryssanthou E, Petrini B (2003) Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery. Acta Paediatr 92:980-982
43. Stratov I, Korman TM, Johnson PD (2003) Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 22:277-283
44. Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ (2002) Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 34:1648-1650